| 研究生: |
邵雅惠 Shao, Ya-Hui |
|---|---|
| 論文名稱: |
探討和轉譯作用抑制因子-4E-BP3有交互作用的蛋白質 Study on the proteins that interact with 4E-BP3,a repressor of cap-dependent translation |
| 指導教授: |
張敏政
Chang, Ming-Cheng |
| 學位類別: |
碩士 Master |
| 系所名稱: |
醫學院 - 生物化學暨分子生物學研究所 Department of Biochemistry and Molecular Biology |
| 論文出版年: | 2005 |
| 畢業學年度: | 93 |
| 語文別: | 中文 |
| 論文頁數: | 85 |
| 中文關鍵詞: | 複製蛋白 、轉譯作用 |
| 外文關鍵詞: | replication protein, translation |
| 相關次數: | 點閱:134 下載:1 |
| 分享至: |
| 查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
中文摘要
4E-BP3為一個分子量14.6 kDa之蛋白,屬於4E-BPs家族的一員。過去研究發現去磷酸化的4E-BPs會與eIF4G競爭eIF4E的結合位置,使得cap-mRNA無法帶入43S pre-initiation complex,因而抑制轉譯的速率,對於細胞生長有負向調節的功能。因此,4E-BP3可以說是轉譯作用的一個抑制因子。本實驗室先前利用Yeast-Two Hybrid之方法,成功地由人類乳腺細胞基因庫中,篩選出另一個為32-kDa的replication protein A ( RPA) 次單元體-RPA2,會與4E-BP3有交互作用。RPA為一單股DNA結合蛋白,普遍存於真核細胞之細胞核中,主要是由RPA1、RPA2及RPA3三個次體組成一穩定複合物,且其功能牽涉到DNA複製、修補以及基因重組等生理反應。主要與單股DNA產生結合能力的為RPA1,而RPA2則是當細胞進入S phase時,會有磷酸化的現象產生,直到M phase的晚期才去磷酸。若是當細胞遭受到紫外光 (UV) 、游離輻射 (IR) 的照射,而對細胞造成損傷時,RPA2則會有高度磷酸化現象的發生。在本實驗中, 首先利用免疫沈澱的方法,確認了RPA2和4E-BP3發生交互作用是在細胞核內。以m7-GTP sepharose沈澱法則觀察到RPA2/4E-BP3在細胞核內的交互作用也包含 eIF4E。接著,利用先前所建立在HEK293會持續穩定表現4E-BP3蛋白的細胞株(SBP3)來進行去除生長因子(starvation) 的實驗。根據實驗結果,當SBP3處於starvation時,4E-BP3在Thr-23的磷酸化會減少,但與eIF4E的結合能力卻也相對的下降; 這是與4E-BP1非常不同的。另一方面,當SBP3施予starvation時,4E-BP3和RPA2在細胞核內的交互作用則約有百分之九十的增加。由於4E-BP1只存在於細胞質,而4E-BP3則可存在於細胞質和細胞核。因此,我們推測4E-BP3的生理功能更為複雜,而其調控機制則有待更進一步的探討。在細胞受曝照UV的刺激模式實驗中,根據細胞曝射UV後不同時間點的觀察,在外送4E-BP3蛋白的HEK293細胞顯示,RPA2和4E-BP3在細胞核內失去結合關係則發生的相當快,經UV刺激後十五分鐘即產生變化,約在UV 照射二十分鐘內即完全失去結合能力; 然而,RPA2則在UV照射兩小時後開始有高度磷酸化現象。由上述的實驗結果,我們初步推測RPA2和4E-BP3的交互作用並非取決於RPA2磷酸化狀態。為了更進一步了解內生性4E-BP3的調控機制是否和超表現的4E-BP3類似,我們使用一株人類前列腺癌細胞-LNCaP來做實驗,而此細胞已被證實有大量內生性4E-BP3的表現。截至目前為止,我們發現LNCaP在正常培養狀況時,不論是在細胞質或細胞核,4E-BP3在Thr-23都呈現高度磷酸化,而當LNCaP處於starvation時,4E-BP3在Thr-23的磷酸化則也是減少的現象,與SBP3中觀察到的一樣。然而,不論LNCaP進行starvation 二十四小時或四十八小時,4E-BP3分別與eIF4E、RPA2的交互作用似乎沒有變化。因此,我們推測LNCaP是一株對於血清不敏感的癌細胞。但若施予介白素-六 (interlukin-6)刺激,我們觀察到STAT3會先被活化,伴隨著4E-BP3在Thr-23的磷酸化下降;而此時,RPA2和4E-BP3的交互作用則有顯著的提高。另外,對LNCaP 細胞使用PI3K的抑制劑-LY294002則發現: 4E-BP3在Thr-23位置的磷酸化只受到局部的抑制。除此之外,我們利用定點突變的方法來決定4E-BP3蛋白本身哪些磷酸化區域對於4E-BP3/eIF4E以及4E-BP3/RPA2交互作用是最重要的。關於4E-BP3在LNCaP細胞受到不同的刺激下所引發的磷酸化機制及訊號傳遞則有待更進一步的印證和探討。
Abstract
The eukaryotic initiation factor 4E-binding protein 3 (4E-BP3), a member of 4E-BPs family, is a 14.6-kDa protein that is able to compete with eIF4G for binding to eIF4E (eukaryotic initiation factor 4E), thereby stifling eIF4F complex-directed translation. Therefore, the function of 4E-BP3 is a repressor of cap-dependent translation. In our previous studies, a yeast two-hybrid system using a 32-kDa subunit of replication protein A (RPA2) as a bait was performed and the results showed that RPA2 is able to interact with the 4E-BP3. RPA is a heterotrimeric (70-, 32- & 14-kDa subunits) single-stranded DNA-binding protein that is required for DNA replication, recombination and repair. The primary ssDNA binding activity is localized to the 70-kDa subunit (RPA1). However, RPA2 is phosphorylated in a cell cycle dependent manner and is additionally phosphorylated in response to DNA damage. Hyperphosphorylation of RPA2 occurs in response to DNA-damaging agents, such as UV or IR treatment. In this study, in vitro immunoprecipitation assay was performed to confirm that RPA2-4E-BP3 complex was located in the nuclear fraction. M7-GTP sepharose pull down assay showed that the complex of RPA2 and 4E-BP3 isolated from nuclear fraction of the HEK293 cell containing overexpression of His/c-Myc- tagged 4E-BP3 (SBP3), also containing eIF4E. We also observed that serum-starvation of SBP3 for 24 hours resulted in a significant reduction in the phosphorylation of 4E-BP3 at Thr-23 phosphorylated site and this coincided with a decrease association of 4E-BP3 and eIF4E. However, a 90% increase in the amount of 4E-BP3 bound to RPA2 in the nuclear fraction of serum-starvated SBP3 was detected. The dephosphorylation of 4E-BP3 at Thr-23 and 4E-BP3 dissociated from eIF4E upon serum-starvation is different from that of 4E-BP1, in which dephosphorylation of the equivalent site (Thr-37) in 4E-BP1 leads to association of 4E-BP1 with eIF4E after serum-starvation. Consequently, we presume that the biological function of 4E-BP3 is more complicated, so its regulatory mechanism still needs further investigation. In UV-stimulated experiments, when HEK293 cell transiently transfected with 4E-BP3 was treated with 50 J/m2 of UV, the dissociation of RPA2 and 4E-BP3 was detected at 15 minutes, and no RPA2 - 4E-BP3 complex was detected at 20 minutes in the nuclear fraction after UV damage, but the phosphorylated form of RPA2 was detected after 2 hours. These data indicated that the phosphorylation of RPA2 did not cause 4E-BP3 losing the binding ability to RPA2 in the HEK293 cell. In order to study the behavior of endogenous 4E-BP3, we used a human prostate carcinoma cell line-LNCaP, which was proved to overexpress endogenous 4E-BP3. We found that 4E-BP3 was phosphorylated not only in the cytoplasmic but also in the nuclear fractions in LNCaP cells under normal culture condition. When LNCaP cells were under serum-starvation situation, the phosphorylation of 4E-BP3 at Thr-23 also decreased as detected in SBP3. However, the interactions of 4E-BP3/eIF4E and 4E-BP3/RPA2 didn’t change in serum-starvation and normal circumstances. These results implied that LNCaP was serum-insensitive. Additionally, we treated the LNCaP cells with interleukin (IL)-6 or the inhibitor of PI3K, LY294002. Our propaedeutic data indicated that upon IL-6 stimulation, the LNCaP cells exhibited a dramatic increase in STAT3 transcriptional activity, the phosphorylation of 4E-BP3 at Thr-23 decreased, and the association of 4E-BP3 and RPA2 increased. Whereas when treated the LNCaP cells with PI3K inhibitor, LY294002, only a limited level of phosphorylated form of 4E-BP3 was detected. Besides, we used site-directed mutagenesis to determine which phosphorylation sites on 4E-BP3 are important for eIF4E and RPA2 binding. To further address the phosphorylation mechanism and signal transduction of 4E-BP3 in the LNCaP cells under various conditions will be investigated.
參考文獻
Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15, 2177-96, 2001
Abramova NA, Russell J, Botchan M, Li R. Interaction between replication protein A and p53 is disrupted after UV damage in a DNA repair-dependent manner. Proc. Natl. Acad. Sci. USA 94, 7186-7191, 1997
Adachi Y, Laemmli UK. Identification of nuclear pre-replication centers poised for DNA synthesis in Xenopus egg extracts: immunolocalization study of replication protein. A. J. Cell Biol. 119, 1-15, 1992
Barr SM, Leung CG, Chang EE, Cimprich KA. ATR kinase activity regulates the intranuclear translocation of ATR and RPA following ionizing radiation. Curr Biol. 13, 1047-51, 2003
Binz SK, Lao Y, Lowry DF, Wold MS. The phosphorylation domain of the 32-kDa subunit of replication protein A (RPA) modulates RPA-DNA interactions. Evidence for an intersubunit interaction. J Biol Chem. 278, 35584-91, 2003
Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy. Nat Rev Cancer. 4, 335-48, 2004
Blackwell LJ, Borowiec JA, Masrangelo IA. Single-stranded DNA binding alters human replication protein A structure and facilitates interaction with DNA-dependent protein kinase. Mol. Cell. Biol. 16, 4798-4806, 1996
Bochkarev A, Bochkareva E, Frappier L, Edwards AM. The crystal structure of the complex of replication protein A subunits RPA32 and RPA14 reveals a mechanism for single-stranded DNA binding. EMBO J. 18, 4498-4504, 1999
Brush GS, Anderson CW, Kelly TJ. The DNA-activated protein kinase is required for the phosphorylation of replication protein A during simian virus 40 DNA replication. Proc. Natl. Acad. Sci. USA 91, 12520-12524, 1994
Brunn GJ, Hudson CC, Sekulic A, Williams JM, Hosoi H, Houghton PJ, Lawrence JC Jr, Abraham RT. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science. 277, 99-101, 1997
Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr, Abraham RT. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15, 5256-5267, 1996
Cardoso MC, Leonhardt H, Nadal-Ginard B. Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74, 979-792, 1993
Carty MP, Levine AS, Dixon K. HeLa cell single-stranded DNA-binding protein increases the accuracy of DNA synthesis by DNA polymerase alpha in vitro. Mutat Res. 274, 29-43, 1992
Chen T, Wang LH, Farrar WL. Interlukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res. 60, 2132-35, 2000
Chung TD, Yu JJ, Kong TA, Spiotto MT, Lin JM. Interlukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines. Prostate. 42, 1-7, 2000
Clemens MJ. Translational regulation in cell stress and apoptosis. Roles of the eIF4E binding proteins. J Cell Mol Med. 5, 221-39, 2001
Clemens MJ. Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene. 23, 3180-8, 2004
Cohen N, Sharma M, Kentsis A, Perez JM, Strudwick S, Borden KL. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA. EMBO J. 20, 4547-59, 2001
Daughdrill GW, Ackerman J, Isern NG, Botuyan MV, Arrowsmith C, Wold MS, Lowry DF. The weak interdomain coupling observed in the 70 kDa subunit of human replication protein A is unaffected by ssDNA binding. Nucleic Acids Res. 29, 3270-6, 2001
De Benedetti A, Harris AL. eIF4E expression in tumors: its possible role in progression of malignancies. Int. J. Biochem. Cell Biol. 31, 59-72, 1999
Din S, Brill SJ, Fairman MP, Stillman B. Cell-cycle-regulated phosphorylation of DNA replication factor A from human and yeast cells. Genes Dev. 4, 968-977, 1990
Dutta A, Stillman B. Cdc2 family kinases phosphorylate a human cell DNA replication factor, RPA, and activate DNA replication. EMBO J. 11, 2189-2199, 1992
Fadden P, Haystead TA, Lawrence JC Jr. Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes. J Biol Chem. 272, 10240-7, 1997
Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol. 24, 200-16, 2004
Fleurent M, Gingras AC, Sonenberg N, Meloche S. Angiotensin II stimulates phosphorylation of the translational repressor 4E-binding protein 1 by a mitogen-activated protein kinase-independent mechanism. J. Biol. Chem. 272, 4006-4012, 1997
Foukas LC, Shepherd PR. eIF4E binding protein 1 and H-Ras are novel substrates for the protein kinase activity of class-I phosphoinositide 3-kinase. Biochem Biophys Res Commun. 319, 541-9, 2004
Georgaki A, Hubscher U. DNA unwinding by replication protein A is a property of the 70 kDa subunit and is facilitated by phosphorylation of the 32 kDa subunit. Nucleic Acids Res. 21, 3659-3665, 1993
Gingras AC, Kennedy SG, O'Leary MA, Sonenberg N, Hay N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt (PKB) signaling pathway. Genes Dev. 12, 502-13, 1998
Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13, 1422-1437, 1999
Gingras AC. Raught B. Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68, 913-963, 1999
Graves LM, Bornfeldt KE, Argast GM, Krebs EG, Kong X, Lin TA, Lawrence JC Jr. cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA 92, 7222-7226, 1995
Gomes XV, Wold MS. Structural analysis of human replication protein A. Mapping functional domains of the 70 kDa subunit. J. Biol. Chem. 270, 4534-4543, 1995
Gomes XV, Henricksen LA, Wold MS. Proteolytic mapping of human replication protein A: evidence for multiple structural domains and a conformational change upon interaction with single-stranded DNA. Biochemistry 35, 5586-5595, 1996
Haghighat A, Mader S, Pause A, Sonenberg N. Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J. 14, 5701-5709, 1995
Hahm B, Kim YK, Kim JH, Kim TY, Hahm B SK. Heterogeneous nuclear ribonucleoprotein L interacts with the 3' border of the internal ribosomal entry site of hepatitis C virus. J. Virol. 72, 8782-8788, 1998
Heesom KJ, Gampel A, Mellor H, Denton RM. Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1). Curr. Biol. 11, 1374-1397, 2001
Henricksen LA, Wold MS. Replication protein A mutants lacking phosphorylation sites for p34cdc2 kinase support DNA replication. J. Biol. Chem. 269, 1121-1132, 1994
Henricksen LA, Carter T, Dutta A, Wold MS. Phosphorylation of human replication protein A by the DNA dependent protein kinase DNA dependent protein kinase is involved in the modulation of DNA replication. Nucleic Acids Res. 24, 433-440, 1996
Huang S, Houghton PJ. Targeting mTOR signaling for cancer therapy. Curr Opin Pharmacol. 3, 371-7, 2003
Kerekatte V, Smiley K, Hu B, Smith A, Gelder F, De Benedetti A. The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int. J. Cancer 64, 27-31, 1995
Kenny MK, Lee SH, Hurwitz J. Multiple functions of human single-stranded-DNA binding protein in simian virus 40 DNA replication: single-strand stabilization and stimulation of DNA polymerases alpha and delta. Proc. Natl. Acad. Sci. USA 86, 9757-9761, 1989
Kirchgessner CU, Patil CK, Evans JW, Cuomo CA, Fried LM, Carter T, Oettinger MA, Brown JM. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267, 1178-1183, 1995
Kleijn M, Scheper GC, Wilson ML, Tee AR, Proud CG. Localisation and regulation of the eIF4E-binding protein 4E-BP3. FEBS Lett. 532, 319-23, 2002
Kleijn M, Scheper GC, Voorma HO, Thomas AA. Regulation of translation initiation factors by signal transduction. Eur J Biochem. 253, 531-44, 1998
Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell Biol. 115, 887-903, 1991
Lawrence JC Jr, Abraham RT. PHAS/4E-BPs as regulators of mRNA translation and cell proliferation. Trends Biochem Sci. 22, 345-9, 1997
Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic translation initiation factor subunit that binds to mRNA cap. Nature 345, 544-547, 1990
Lee SH, Kim DK, Drissi R. Human xeroderma pigmentosum group A protein interacts with human replication protein A and inhibits DNA replication. J. Biol. Chem. 270, 12801-12807, 1995
Lejbkowicz F, Goyer C, Darveau A, Neron S, Lemieux R, Sonenberg N. A fraction of the mRNA 5' cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus. Proc Natl Acad Sci U S A. 89, 9612-6, 1992
Lin TA, Kong X, Saltiel AR, Blackshear PJ, Lawrence JC Jr. Control of PHAS-I by insulin in 3T3-L1 adipocytes synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway. J. Biol. Chem. 270, 18531-18538, 1995
Lin YL, Chen C, Keshav KF, Winchester E, Dutta A. Dissection of functional domains of the human DNA replication protein complex replication protein A. J. Biol. Chem. 271, 17190-17198, 1996
Liu VF, Weaver DT. The ionizing radiation-induced replication protein A phosphorylation response differs between ataxia telangiectasia and normal human cell. Mol. Cell. Biol. 13, 7222-7231, 1993
Loo YM, Melendy T. The majority of human replication protein A remains complexed throughout the cell cycle. Nucleic Acids Res. 28, 3354-60, 2000
Lou W, Ni Z, Dyer K, Tweardy DJ, Gao AC. Interlukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway. Prostate. 42, 239-42, 2000
Mader S, Lee H, Pause A, Sonenberg N. The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins. Mol. Cell. Biol. 15, 4990-4997, 1995
Mer G, Bochkarev A, Gupta R, Bochkareva E, Frappier L, Ingles CJ, Edwards AM, Chazin WJ. Structural Basis for the Recognition of DNA Repair Protein UNG2, XPA, and RAD52 by Replication Factor RPA. Cell 103, 449-456, 2000
Miyagi Y, Sugiyama A, Asai A, Okazaki T, Kuchino Y, Kerr SJ. Elevated levels of eukaryotic translation initiation factor eIF-4E, mRNA in a broad spectrum of transformed cell lines. Cancer Lett 91, 247-252, 1995
Niu H, Erdjument-Bromage H, Pan ZQ, Lee SH, Tempst P, Hurwitz J. Mapping of amino acid residues in the p34 subunit of human single-stranded DNA-binding protein phosphorylated by DNA-dependent protein kinase and Cdc2 kinase in vitro. J. Biol. Chem. 272, 12634-12641, 1997
Pan ZQ, Amin AA, Gibbs E, Niu H, Hurwitz J. Phosphorylation of p34 subunit of human single-stranded-DNA-binding protein in cyclin A-activated G1 extracts is catalyzed by cdk-cyclin A complex and DNA-dependent-protein kinase. Proc. Natl. Acad. Sci. USA 91, 8343-8347, 1994
Pain VM. Initiation of protein synthesis in eukaryotic cells. Eur. J. Biochem. 236, 747-771, 1996
Pause A, Belsham GJ, Gingras AC, Donze O, Lin TA, Lawrence JC Jr, Sonenberg N. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5’-cap function. Nature 371, 762-767, 1994
Pause A, Sonenberg N. Mutational analysis of a DEAD box RNA helicase: the mammalian translation initiation factor eIF-4A. EMBO J. 11, 2643-54, 1992
Pelletier J, Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334, 320-325, 1988
Pfuetzner RA, Bochkarev A, Frappier L, Edwards AM. Replication protein A. Characterization and crystallization of the DNA binding domain. J. Biol. Chem. 272, 430-434, 1997
Philipova D, Mullen JR, Maniar HS, Lu J, Gu C, Brill SJ. A hierarchy of SSB protomers in replication protein A. Genes Dev. 10, 2222-2233, 1996
Poulin F, Gingras AC, Olsen H, Chevalier S, Sonenberg N. 4E-BP3, a new member of the Eukaryotic initation factor 4E-binding protein family. J. Biol. Chem. 273, 14002-14007, 1998
Raught B, Gingras AC. eIF4E activity is regulated at multiple levels. Int J Biochem Cell Biol. 31, 43-57, 1999
Rau M, Ohlmann T, Morley SJ, Pain VM. A reevaluation of the cap-binding protein, eIF4E, as a rate-limiting factor for initiation of translation in reticulocyte lysate. J Biol Chem. 271, 8983-90, 1996
Richter JD, Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature. 433, 477-480, 2005
Rousseau D, Gingras AC, Pause A, Sonenberg N. The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene 13, 2415-2420, 1996
Seo YS, Lee SH, Hurwitz J. Isolation of a DNA helicase from HeLa cells requiring the multisubunit human single-stranded DNA-binding protein for activity. J. Biol Chem. 266, 13161-13170, 1991
Shao RG, Cao CX, Zhang H, Kohn KW, Wold MS, Pommier Y. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA: DNA-PK complexes. EMBO J. 18, 1397-1406, 1999
Sonenberg N, Gingras AC. The mRNA 5’-cap-binding protein eIF4E and control of cell growth. Curr. Opin. Cell. Biol. 10, 268-275, 1998
Spiotto MT, Chung TD. STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP. Prostate.42, 88-98, 2000
Sukhodolets KE, Hickman AB, Agarwal SK, Sukhodolets MV, Obungu VH, Novotny EA, Crabtree JS, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ. The 32-Kilodalton Subunit of Replication Protein A Interacts with Menin, the Product of the MEN1 Tumor Suppressor Gene. Mol. Cell. Biol. 23, 493-509, 2003
Strudwick S, Borden KL. The emerging roles of translation factor eIF4E in the nucleus. Differentiation. 70, 10-22, 2002
Tee AR, Proud CG. Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif. Mol Cell Biol. 22, 1674-83, 2002
Tee AR, Proud CG. DNA-damaging agents cause inactivation of translational regulators linked to mTOR signaling. Oncogene. 19, 3021-31, 2000
Treuner K, Ramsperger U, Knippers R. Replication protein A induces the unwinding of long double-stranded DNA regions. J Mol Biol. 259, 104-12, 1996
Vassin VM, Wold MS, Borowiec JA. Replication protein A (RPA) phosphorylation prevents RPA association with replication centers. Mol Cell Biol. 24, 1930-43, 2004
Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet. 9, 138-141, 1993
Von Der Haar T, Gross JD, Wagner G, McCarthy JE. The mRNA cap-binding protein eIF4E in post-transcriptional gene expression. Nat Struct Mol Biol. 11, 503-11, 2004
von Manteuffel SR, Gingras AC, Ming XF, Sonenberg N, Thomas G. 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 93, 4076-4080, 1996
Wang H, Guan J, Wang H, Perrault AR, Wang Y, Iliakis G. Replication Protein A2 Phosphorylation after DNA Damage by the Coordinated Action of Ataxia Telangiectasia-Mutated and DNA-dependent Protein Kinase. Cancer Res. 61, 8554-8563, 2001
Wang X, Li W, Parra JL, Beugnet A, Proud CG. The C terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylation. Mol Cell Biol. 23, 1546-57, 2003
Wobbe CR, Weissbach L, Borowiec JA, Dean FB, Murakami Y, Bullock P, Hurwitz J. Replication of simian virus 40 origin-containing DNA in vitro with purified proteins. Proc. Natl. Acad. Sci. USA 84, 1834-1838, 1987
Wold MS. Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem. 66, 61-92, 1997
Zhang X, Shu L, Hosoi H, Murti KG, Houghton PJ. Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture. J Biol Chem. 277, 28127-34, 2002
陳嘉玲,探討RPA2與4E-BP3的交互作用及其可能的生理角色。國立成功大學醫學院生物化學研究所碩士論文,2002。
蘇榆芳,探討與RPA2有交互作用之蛋白的研究。國立成功大學醫學院生物化學研究所碩士論文,2003。
王佩文,複製蛋白RPA2與mRNA轉譯作用抑制蛋白4E-BP3間交互作用之探討。國立成功大學醫學院生物化學研究所碩士論文,2004。